Skip to main content

Advances in Blood Cell Labeling: Pretargeting

  • Chapter
Radiolabeled Blood Elements

Part of the book series: NATO ASI Series ((NSSA,volume 262))

  • 76 Accesses

Abstract

The high sensitivity and specificity of the 111In labeled WBC method make it the “gold standard” against which all the new methods must be measured. However the 111In WBC method requires laborious separation, labeling and reinjection of 111In oxine labeled autologous leukocytes. With the increasing incidence of AIDS there is now the possibility of misadministration of HIV infected cells with disastrous consequences. Radiation exposure from a diagnostic misadministration pales into insignificance by comparison. There is also a small but finite chance of self-infection from a needle stick. These reasons, along with simplicity, are all persuasive arguments for the continued development of kit preparations wherever possible. Thus new approaches amenable to kit formulations, such as human polyclonal immuno-globulin and anti-leukocyte MABsa labeled with either 99mTc or 111In are very attractive alternatives.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

eBook
USD 16.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Fischman AJ, Rubin RH, Khaw BA, et al. Detection of acute inflammation with 111In-labelled non-specific polyclonal IgG. Semin Nucl Med; 18: 335–344 (1988).

    Article  PubMed  CAS  Google Scholar 

  2. Buscome JR, Lui D, Ensing G, de Jong R, Ell PJ. 99mTc-human immunoglobulin (HIG)-first results of a new agent for the localization of infection and inflammation. Eur J Nucl Med; 16: 649–655 (1990).

    Article  Google Scholar 

  3. McAfee JG, Gagne G, Subramanian G, and Schneider RF. The localization of Indium-I11-leucocytes, Gallium-67-Polyclonal IgG and other radioactive agents in acute focal inflammatory lesions. J Nucl Med; 32: 2126–2131 (1991).

    PubMed  CAS  Google Scholar 

  4. Reardon DT, Meares CF, Goodwin DA, et al: Antibodies against metal chelates. Nature; 316: 265–268 (1985).

    Article  Google Scholar 

  5. Goodwin DA, Meares CF, McCall MJ, McTigue M, Chaovapong W. Pre-targeted immunoscintigraphy of murine tumors with indium-111 labeled bifunctional haptens. J Nucl Med;, 29: 226–234 (1988).

    PubMed  CAS  Google Scholar 

  6. Goodwin DA, Meares CF, McCall MJ, Chaovapong W, McTigue M, Diamante CI: Pretargeted immunoscintigraphy with In-111, Ga-67 and Ga-68 labeled bivalent (“Janus”) haptens. J Clin Nuc Med, 13:9Spl0 (Abstract A3) (1988).

    Google Scholar 

  7. Le Doussal M, Martin M, Gautherot E, Delaage M, and Barbet J. In vitro and in vivo targeting of radiolabeled monovalent and divalent haptens with dual specificity monoclonal antibody conjugates: enhanced divalent hapten affinity for cell-bound antibody conjugate. J Nucl Med; 30: 1358–1366 (1989).

    PubMed  Google Scholar 

  8. Karush F. Multivalent binding and functional affinity. Contemp Top Mol Immunol; 5: 217 (1976).

    Google Scholar 

  9. Goodwin DA. Strategies for antibody targeting. Antibody, Immunoconjugates, and Radiopharmaceuticals; 4(4): 427–434 (1991).

    CAS  Google Scholar 

  10. Hnatowitch DJ, Virzi F, and Ruskovski M. Investigations of avidin and biotin for imaging applications. J Nucl Med;, 28:1294–1302 (1987).

    Google Scholar 

  11. Goodwin DA, Meares CF, McCall MJ, McTigue M. An avidin-biotin chelate system for imaging tumors. J Nucl Med; 28:722 (abst) (1987).

    Google Scholar 

  12. Paganelli G, Magnani P, Zito F, et al. Three-step monoclonal antibody tumor targeting in carcinoembryonic antigen-positive patients. Ca Res; 51: 5960–5966 (1991).

    CAS  Google Scholar 

  13. Goodwin DA, Meares CF, McTiue M, Caovapong W, Ransone C, Renn O, McCall MJ, Studer M. Pharmacokinetics of biotin-chelate conjugates for pretargeted avidin-biotin immunoscintigraphy. J Nucl Med; 33: 880 [abstract] (1992).

    Google Scholar 

  14. Rusckowski M, Paganelli G, Hnatowich DJ, Virzi F, Fogarasi M, Fazio F. Imaging infection/inflammation in patients with streptavidin and radiolabeled biotin: preliminary observations. J Nucl Med; 33: 924 [abstract] (1992).

    Google Scholar 

  15. Ruskovsky M, Fritz BS, Hnatowich DJ. Localization of infection using streptavidin and biotin: an alternative to nonspecific polyclonal IgG. J Nucl Med; 33: 1810–1815 (1992).

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1994 Springer Science+Business Media New York

About this chapter

Cite this chapter

Goodwin, D.A. et al. (1994). Advances in Blood Cell Labeling: Pretargeting. In: Martin-Comin, J., Thakur, M.L., Piera, C., Roca, M., Lomeña, F. (eds) Radiolabeled Blood Elements. NATO ASI Series, vol 262. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-2462-5_1

Download citation

  • DOI: https://doi.org/10.1007/978-1-4615-2462-5_1

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4613-6048-3

  • Online ISBN: 978-1-4615-2462-5

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics